APA (7th ed.) Citation

Amnuaywattakorn, S., Charoenphun, P., Ativitavas, T., Pasawang, P., Khamwan, K., Thongpraparn, T., . . . Chuamsaamarkkee, K. (2026). First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach. Molecular Imaging & Radionuclide Therapy, 35(1), 78. https://doi.org/10.4274/mirt.galenos.2026.28863

Chicago Style (17th ed.) Citation

Amnuaywattakorn, Sasithorn, et al. "First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach." Molecular Imaging & Radionuclide Therapy 35, no. 1 (2026): 78. https://doi.org/10.4274/mirt.galenos.2026.28863.

MLA (9th ed.) Citation

Amnuaywattakorn, Sasithorn, et al. "First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach." Molecular Imaging & Radionuclide Therapy, vol. 35, no. 1, 2026, p. 78, https://doi.org/10.4274/mirt.galenos.2026.28863.